Gene Therapy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Gene therapy is a cutting-edge medical approach that involves manipulating a person's genes to treat or even cure diseases. This revolutionary technique encompasses various mechanisms to achieve its objectives: Replacing Faulty Genes: One approach is substituting disease-causing genes with healthy counterparts, effectively restoring normal gene function within the individual's cells. Inactivating Dysfunctional Genes: Some gene therapies focus on deactivating genes malfunctioning or causing diseases, thereby mitigating their harmful effects. Introducing Modified Genes: Another method involves introducing new or modified genes into the body to combat specific diseases or medical conditions. Primarily confined to research laboratories, gene therapy is still experimental. However, it rapidly evolves into a viable therapeutic option and combines gene therapy with other treatments like immune modulation, chemotherapy, and radiotherapy. Gene therapy can be broadly classified into two categories: germinal and somatic. Germinal gene therapy involves introducing genes into somatic cells and an individual's germline. It not only cures the genetic disease but can also pass the altered trait to some of the individual's gametes. On the other hand, somatic gene therapy targets non-reproductive or somatic tissues to correct genetic diseases. Dysfunctional cells are removed and replaced with cloned wild-type genes. These corrected genes then provide the necessary function to alleviate disease symptoms. Typically, not all affected cells need modification, only enough to alleviate symptoms. Gene therapy products are being researched for their potential to treat diseases such as cancer, genetic disorders, and infectious diseases. Several types of gene therapy products are being explored: Plasmid DNA: Circular DNA molecules engineered to carry therapeutic genes into human cells. Viral Vectors: Modified viruses with their infectious capabilities removed, used as vehicles to deliver therapeutic genes into human cells. Bacterial Vectors: Non-harmful bacteria serving as carriers to transport therapeutic genes into human tissues. Human Gene Editing Technology: Gene editing aims to disrupt harmful genes or repair mutated ones. Patient-Derived Cellular Gene Therapy Products: Cells are extracted from the patient, genetically modified (often using viral vectors), and reintroduced into the patient's body. Gene therapy holds immense promise for the future of medicine, offering effective treatment and potential eradication of a wide range of diseases.

Thelansis’s “Gene Therapy Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Gene Therapy treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Gene Therapy across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Gene Therapy Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Gene Therapy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypoglycemia and severe
Read more